Suppr超能文献

囚犯的药物使用和阿片类药物替代治疗。

Drug use and opioid substitution treatment for prisoners.

机构信息

Institute of Addiction Research, University of Applied Sciences, Nibelungenplatz 1, D-60318 Frankfurt am Main, Germany.

出版信息

Harm Reduct J. 2010 Jul 19;7:17. doi: 10.1186/1477-7517-7-17.

Abstract

Drug use is prevalent throughout prison populations, and, despite advances in drug treatment programmes for inmates, access to and the quality of these programmes remain substantially poorer than those available for non-incarcerated drug users. Because prisoners may be at greater risk for some of the harms associated with drug use, they deserve therapeutic modalities and attitudes that are at least equal to those available for drug users outside prison. This article discusses drug use by inmates and its associated harms. In addition, this article provides a survey of studies conducted in prisons of opioid substitution therapy (OST), a clinically effective and cost-effective drug treatment strategy. The findings from this overview indicate why treatment efforts for drug users in prison are often poorer than those available for drug users in the non-prison community and demonstrate how the implementation of OST programmes benefits not only prisoners but also prison staff and the community at large. Finally, the article outlines strategies that have been found effective for implementing OST in prisons and offers suggestions for applying these strategies more broadly.

摘要

药物滥用在监狱人群中普遍存在,尽管囚犯的药物治疗方案有所进步,但获得和这些方案的质量仍然远远低于非监禁药物使用者。由于囚犯可能面临与药物使用相关的某些危害的风险更大,因此他们应该获得至少与监狱外药物使用者相同的治疗方式和态度。本文讨论了囚犯的药物使用及其相关危害。此外,本文还对在监狱中进行的阿片类药物替代疗法(OST)的研究进行了调查,OST 是一种临床有效且具有成本效益的药物治疗策略。该综述的结果表明,为什么监狱中药物使用者的治疗效果往往不如非监禁社区中的药物使用者,以及说明了实施 OST 计划如何不仅使囚犯受益,而且使监狱工作人员和整个社区受益。最后,文章概述了在监狱中实施 OST 已被证明有效的策略,并为更广泛地应用这些策略提出了建议。

相似文献

1
Drug use and opioid substitution treatment for prisoners.
Harm Reduct J. 2010 Jul 19;7:17. doi: 10.1186/1477-7517-7-17.
2
Continuity of opioid substitution treatment between prison and community in Southeast Asia: A scoping review.
Int J Drug Policy. 2023 Feb;112:103957. doi: 10.1016/j.drugpo.2023.103957. Epub 2023 Jan 22.
3
Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
Swiss Med Wkly. 2013 Nov 1;143:w13898. doi: 10.4414/smw.2013.13898. eCollection 2013.
6
9
[Guidelines for substitution treatments in prison populations].
Encephale. 2005 Jan-Feb;31(1 Pt 1):92-7. doi: 10.1016/s0013-7006(05)82377-2.

引用本文的文献

2
Development and use of a checklist for the implementation of medication for opioid use disorder in jails.
Implement Res Pract. 2022 Jun 7;3:26334895221101214. doi: 10.1177/26334895221101214. eCollection 2022 Jan-Dec.
4
OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis.
Clinicoecon Outcomes Res. 2020 Sep 9;12:499-504. doi: 10.2147/CEOR.S256714. eCollection 2020.
5
Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study.
Front Psychiatry. 2020 Aug 12;11:794. doi: 10.3389/fpsyt.2020.00794. eCollection 2020.
8
Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach.
Subst Abuse Treat Prev Policy. 2020 Mar 10;15(1):21. doi: 10.1186/s13011-020-00262-w.
9
Optimising opioid substitution therapy in the prison environment.
Int J Prison Health. 2019 Dec 5;15(4):293-307. doi: 10.1108/IJPH-12-2017-0061.
10
Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.
Drug Alcohol Depend. 2018 Dec 1;193:42-47. doi: 10.1016/j.drugalcdep.2018.09.003. Epub 2018 Oct 6.

本文引用的文献

1
A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.
J Subst Abuse Treat. 2009 Oct;37(3):277-85. doi: 10.1016/j.jsat.2009.03.002. Epub 2009 Mar 31.
4
Interventions to reduce HIV transmission related to injecting drug use in prison.
Lancet Infect Dis. 2009 Jan;9(1):57-66. doi: 10.1016/S1473-3099(08)70305-0.
5
Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
Drug Alcohol Depend. 2009 Jan 1;99(1-3):222-30. doi: 10.1016/j.drugalcdep.2008.08.006. Epub 2008 Oct 18.
8
Harm reduction and equity of access to care for French prisoners: a review.
Harm Reduct J. 2008 May 21;5:17. doi: 10.1186/1477-7517-5-17.
9
Acute risk of drug-related death among newly released prisoners in England and Wales.
Addiction. 2008 Feb;103(2):251-5. doi: 10.1111/j.1360-0443.2007.02081.x.
10
The impact of substitution treatment in prisons--a literature review.
Int J Drug Policy. 2007 Dec;18(6):464-74. doi: 10.1016/j.drugpo.2006.11.015. Epub 2007 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验